Skip to main content
. 2018 May 2;148(5):721–728. doi: 10.1093/jn/nxy040

FIGURE 4.

FIGURE 4

MiR expression in sera from participants with or at risk for metabolic syndrome at baseline (n = 99) (A). Relative expression is MiR expression after normalization by RNU6 control gene. (B) MiR expression in sera in response to the CanolaDHA and CanolaOleic diets after 28 d in participants with or at risk for metabolic syndrome (n = 99). Values are means + SEMs. *Different from baseline, P < 0.05. CanolaDHA, DHA-enriched high oleic acid–canola oil; CanolaOleic, high oleic acid–canola oil; MiR, microRNA.